Indian court cracks down on 'Bolar exception' loophole to fortify global patent rights
India's Madras High Court has ruled that generic drug makers cannot rely on the statutory Bolar exception to export patented active pharmaceutical ingredients unless they can demonstrate that the exports were...To view the full article, register now.
Already a subscriber? Click here to view full article